Plain-English translation of NCT02916810 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing transcranial magnetic stimulation (TMS)—a non-invasive treatment that uses magnetic pulses to stimulate specific areas of the brain. Researchers believe that by using brain imaging to identify each person's unique brain patterns related to hearing voices, they can target the treatment more precisely and help more patients benefit from it. The goal is to reduce auditory hallucinations in people with schizophrenia who have not fully responded to antipsychotic medications.
While early studies showed promise for TMS in treating hearing voices, results have been inconsistent across larger groups of patients. This trial aims to develop a more personalized approach—using individual brain imaging to customize where and how the treatment is delivered—so that the medication works better for more people.
You likely qualify if…
You likely don't qualify if…
Participants will undergo brain imaging scans to identify their personalized treatment targets, then receive a series of transcranial magnetic stimulation sessions. Some participants will receive active treatment while others receive sham (placebo) stimulation, and researchers will measure changes in hearing voices and other symptoms over time. You would need to commit to regular visits at the research center and maintain contact with study staff, with support from two trusted contacts in your local area.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States